scispace - formally typeset
Patent

Lipid-polymer conjugates and liposomes

TLDR
In this paper, a lipid-polymer conjugate for long-circulating liposomes is presented. But the conjugates do not include a vesicle-forming lipid having convalently attached to its polar head group, such as polyvinylpyrrolidone or polyaspartamide.
Abstract
A lipid-polymer conjugate for use in forming long-circulating liposomes is disclosed. The conjugate includes a vesicle-forming lipid having convalently attached to its polar head group, one of the polymers: polyvinylpyrrolidone, polyvinylmethylether, polyhydroxypropyl methacrylate, polyhydroxypropylmethacrylamide, polyhydroxyethyl acrylate, polymethacrylamide, polydimethylacrylamide, polymethyloxazoline, polyethyloxazoline, polyhydroxyethyloxazoline, polyhydroxypropyloxazoline, or polyaspartamide. A method for preparing liposomes containing the lipid-polymer conjugate is also disclosed.

read more

Citations
More filters
Patent

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

TL;DR: In this paper, a soluble neutral active hyaluronidase glycoprotein (sHASEGP) was proposed to facilitate administration of other molecules or to alleviate glycosaminoglycan associated pathologies.
Patent

Compositions and methods for the diagnosis and treatment of tumor

TL;DR: In this article, an antibody drug conjugate composition of matter useful for the diagnosis and treatment of tumors in mammals and methods of using those compositions of matter for the same were described.
Patent

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

TL;DR: In this paper, compositions and methods for modulating the expression and function of small non-coding RNAs are provided. But the compositions are targeted to small non coding RNAs, and methods of using these compounds for modulation of small NNAs as well as downstream targets of these RNAs and for diagnosis and treatment of disease associated with small NNs.
Patent

Oligoribonucleotides and ribonucleases for cleaving RNA

TL;DR: Oligomeric compounds are useful for diagnostics and other research purposes, for modulating the expression of a protein in organisms, and for the diagnosis, detection and treatment of other conditions susceptible to oligonucleotide therapeutics.
Patent

Bilayer stabilizing components and their use in forming programmable fusogenic liposomes

TL;DR: In this article, a fusogenic liposome is proposed, consisting of a lipid capable of adopting a non-lamellar phase, yet capable of assuming a bilayer structure in the presence of bilayer stabilizing component, which can be used to deliver drugs, peptide, proteins, RNA, DNA or other bioactive molecules.
References
More filters
Journal ArticleDOI

Comparative Properties and Methods of Preparation of Lipid Vesicles (Liposomes)

TL;DR: This research attacked the mode of action of phosphatidylcholine-like deposits in response to the presence of ribonucleic acid by exploiting its role as a “spatially aggregating substance” in the response to EMT.
Book

Poly(ethylene glycol) chemistry : biotechnical and biomedical applications

TL;DR: PEG Derivatized Ligands with Hydrophobic and Immunological Specificity and Preparation and Properties of Monomethoxypoly(Ethylene Glycol)Modified Enzymes for Therapeutic Applications.
Patent

Liposomes with enhanced circulation time

TL;DR: A liposome composition which contains between 1-20 mole percent of an amphipathic lipid derivatized with a polyalkylether, as exemplified by phosphatidylethanolamine derivatised with polyethyleneglycol, is described in this article.
Book

Water-Soluble Synthetic Polymers: Volume I: Properties and Behavior

TL;DR: In this article, the physical chemistry of water-soluble synthetic polymers as a group is surveyed and compared, and their properties and behaviour is correlated with their molecular structures for predictive purposes, and sufficient key recent references are also included so that the existing state of the art is delineated.